At the European Cell and Gene Therapy Summit 2024, confidence in the sector’s maturity and progress was evident, highlighted ...

ViiV Healthcare, the specialist HIV company majority owned by GSK (LSE: GSK), today announced the presentation of new ...

California-based Jaguar Health today announced the US launch of Gelclair, the only Food and Drug Administration ...

The American Lung Association Research Institute has announced a $22 million investment in 2024 to fund 139 research grants ...

Netherlands-based venture capital firm Forbion has raised over €2 billion ($2.2 billion) across its newest funds, bringing ...

Eli Lilly has announced a strategic collaboration with UK government departments to address population health challenges, ...

TenNor Therapeutics has raised over 300 million yuan ($41 million) in a series E round, led by AMR Action Fund, to advance ...

A staggering 800% increase in licensing agreement deal values for messenger ribonucleic acid (mRNA)-based innovator ...

Chinese biopharma Hutchmed (LON: HCM) was trading 5% higher at the mid-point of London’s trading day on Wednesday. The ...

Eli Lilly (NYSE: LLY) has partnered with the UK government, investing £279 million ($340 million) to address public health ...

TRIANA Biomedicines has entered into a strategic collaboration and licensing agreement with US pharma giant Pfizer to ...

The US Food and Drug Administration (FDA) has approved Novocure's Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or ...